EquityFlowCompanies › Cytovation

Cytovation

Biotech · Bergen, NO

Clinical-stage immuno-oncology developing CyPep-1 tumor immunotherapy

Funding history

DateRoundAmount
Jun 2023Series A
Bergen immuno-oncology startup Cytovation added $8M (NOK85M) to its Series A, now over $28M total.
$8M
Feb 2022Series A
Bergen oncology biotech Cytovation raised a 180M kroner (17.69M euro) Series A led by Sandwater and Canica.
$17.7M

Investors

CanicaSandwater

Similar companies in Biotech

Explore funding flow on EquityFlow →